Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

已完结 10 由陶振兴发布于 2025/9/4 18:58:10

DOI:10.1016/j.jchf.2024.11.013
作者：Milind Y. Desai MD, MBA ,?Steve E. Nissen MD ,?Theodore Abraham MD ,?Iacopo Olivotto MD ,?Pablo Garcia-Pavia MD, PhD ,?Renato D. Lopes MD, PhD ,?Nicolas Verheyen MD ,?Omar Wever-Pinzon MD ,?Kathy Wols
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：There are no approved therapies for patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM). The authors describe the baseline characteristics of ODYSSEY-HCM (A Study of

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAutomated identification and tracking of deformation twin structures in molecular dynamics simulations